carvedilol has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; He, Z; Huang, P; Li, J; Luo, Y; Ma, J; Xu, Y | 1 |
1 other study(ies) available for carvedilol and cyclin d1
Article | Year |
---|---|
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Carvedilol; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Guanine Nucleotide Exchange Factors; Humans; Mice; Phosphatidylinositol 3-Kinases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2023 |